首页 正文

Phase II study of avelumab in multiple relapsed/refractory germ cell cancer

{{output}}
Background Germ cell tumors (GCTs) are highly curable diseases; however, not all patients can be cured. Patients in their second relapse have especially poor prognoses. PD-L1 expression is significantly higher in GCTs than in normal testicular tissue, and high... ...